Item 1.01 Entry into a Material Definitive Agreement
On
The Company estimates gross proceeds from the Offering, before deducting the
underwriting discounts and commissions and other estimated offering expenses
payable by the Company, will be approximately
TD Cowen acted as lead book-runner and
The Company made customary representations, warranties and covenants concerning the Company and the Registration Statement in the Underwriting Agreement and also agreed to indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). In addition, subject to certain exceptions, the Company, its officers and directors and certain other holders of the Company's Common Stock have agreed not to offer, sell, transfer or otherwise dispose of any shares of Common Stock during the 90-day period following the date of the Prospectus Supplement.
The foregoing description of certain terms of the Underwriting Agreement and the
transactions contemplated thereby does not purport to be complete and is subject
to, and qualified in its entirety by, the full text of the Underwriting
Agreement, which is attached as Exhibit 1.1 to this Current Report on Form 8-K
and is incorporated herein by reference. The legal opinion of
Item 7.01 Regulation FD Disclosure.
On
The information in this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.
--------------------------------------------------------------------------------
Item 8.01 Other Events
On
Cash Runway Extension
On
Cautionary Note Regarding Forward Looking Statements
This Current Report on Form 8-K and certain of the materials filed herewith
contain forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, as amended, including, without limitation,
statements regarding the Offering. The words "may," "might," "will," "could,"
"would," "should," "expect," "plan," "anticipate," "intend," "believe,"
"expect," "estimate," "seek," "predict," "future," "project," "potential,"
"continue," "target" and similar words or expressions are intended to identify
forward-looking statements, although not all forward-looking statements contain
these identifying words. Any forward-looking statements, such as those related
to the anticipated closing of the Offering, the anticipated gross proceeds from
the Offering, the Company's intended use of proceeds from the Offering and the
Company's expectations regarding its cash runway, are subject to a number of
risks, uncertainties and important factors that may cause actual events or
results to differ materially from those expressed or implied by any
forward-looking statements contained in this Current Report on Form 8-K or the
materials furnished or filed herewith, including, without limitation,
uncertainties related to market conditions and the completion of the Offering on
the anticipated terms or at all. These and other risks and uncertainties are
described in greater detail in the section entitled "Risk Factors" in the
Company's Quarterly Report on Form 10-Q for the quarter ended
Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, datedMay 15, 2023 , by and betweenIkena Oncology, Inc. andCowen and Company, LLC , as representative of the several underwriters named therein. 5.1 Opinion ofGoodwin Procter LLP 23.1 Consent ofGoodwin Procter LLP (included in its opinion filed as Exhibit 5.1) 99.1 Press release issued byIkena Oncology, Inc. onMay 15, 2023 99.2Ikena Oncology Inc. Corporate Presentation 99.3 Press release issued byIkena Oncology, Inc. onMay 15, 2023 104 Cover Page Interactive Data File
--------------------------------------------------------------------------------
© Edgar Online, source